HEALTH● LOWSep 25 · Sep 25, 2026, 9:56 PM
Eli Lilly's Olumiant receives expanded alopecia indication for children 12 and up
Seeking Alpha Tech · global
Eli Lilly's drug Olumiant has received an expanded indication for treating alopecia in children aged 12 and up. This represents a new treatment option for a specific patient population.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoLongevity-first healthcare takes spotlight at Abu Dhabi Future Health SummitSouth China Morning PostHEALTH1h agoKenya’s Ebola cases test preparedness beyond NairobiAl Jazeera [en]HEALTH3h agoEven after explosive diarrhea outbreak Trump’s FDA looks to ease food requirementsThe Independent WorldHEALTH5h agoPope Leo recovers after lung surgeryNBC News